Cargando…

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists

Natural products are an abundant source of potential drugs, and their diversity makes them a rich and viable prospective source of bioactive cannabinoid ligands. Cannabinoid receptor 1 (CB1) antagonists are clinically established and well documented as potential therapeutics for treating obesity, ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Pankaj, Roy, Kuldeep K., Liu, Haining, Ma, Guoyi, Pettaway, Sara, Alsharif, Walid F., Gadepalli, Rama S., Rimoldi, John M., McCurdy, Christopher R., Cutler, Stephen J., Doerksen, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222380/ https://www.ncbi.nlm.nih.gov/pubmed/30322136 http://dx.doi.org/10.3390/molecules23102630

Ejemplares similares

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Modeling cannabinoids from a large-scale sample of Cannabis sativa chemotypes
por: Vergara, Daniela, et al.
Publicado: (2020)

Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors
por: Gogineni, Vedanjali, et al.
Publicado: (2021)

Developmental Plasticity of the Major Alkyl Cannabinoid Chemotypes in a Diverse Cannabis Genetic Resource Collection
por: Welling, Matthew T., et al.
Publicado: (2018)

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
por: Rabbani, Mohammed, et al.
Publicado: (2012)

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
por: Presley, Chaela, et al.
Publicado: (2015)

The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
por: Fuchs, Alexander, et al.
Publicado: (2013)

Oxygenated Polyketides from Plakinastrella mamillaris as a New Chemotype of PXR Agonists
por: Festa, Carmen, et al.
Publicado: (2013)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors
por: Pandey, Pankaj, et al.
Publicado: (2023)

Nigramide J is a novel potent inverse agonist of the human constitutive androstane receptor
por: Kanno, Yuichiro, et al.
Publicado: (2014)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties
por: de Oliveira, Daniela R., et al.
Publicado: (2022)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities
por: Meqbil, Yazan J., et al.
Publicado: (2021)

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries
por: Willems, Sabine, et al.
Publicado: (2022)

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
por: Goonawardena, Anushka V., et al.
Publicado: (2011)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Analysis of Sequence Variability and Transcriptional Profile of Cannabinoid synthase Genes in Cannabis sativa L. Chemotypes with a Focus on Cannabichromenic acid synthase
por: Fulvio, Flavia, et al.
Publicado: (2021)

Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)
por: Senaweera, Sameera, et al.
Publicado: (2022)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

The chemotype core collection of genus Nicotiana
por: Drapal, Margit, et al.
Publicado: (2022)

Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity
por: El-Damasy, Ashraf K., et al.
Publicado: (2023)

Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069
por: Orsi, Douglas L., et al.
Publicado: (2022)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
por: Muller, Tania, et al.
Publicado: (2022)

Correction to “Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069”
por: Orsi, Douglas L., et al.
Publicado: (2022)

In depth investigation of the metabolism of Nectandra megapotamica chemotypes
por: Farias, Katyuce de S., et al.
Publicado: (2018)

Chemotypic Characterization and Biological Activity of Rosmarinus officinalis
por: Satyal, Prabodh, et al.
Publicado: (2017)

TRI Genotyping and Chemotyping: A Balance of Power
por: Villafana, Ria T., et al.
Publicado: (2020)

Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
por: Jin, Dan, et al.
Publicado: (2021)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189
por: Liu, Yu, et al.
Publicado: (2017)

Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen
por: Sharlow, Elizabeth R., et al.
Publicado: (2009)

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
por: Eduful, Benjamin J., et al.
Publicado: (2021)

Absorbance-Transmittance Excitation Emission Matrix Method for Quantification of Major Cannabinoids and Corresponding Acids: A Rapid Alternative to Chromatography for Rapid Chemotype Discrimination of Cannabis sativa Varieties
por: Gilmore, Adam M., et al.
Publicado: (2023)

Chemotyping the distribution of vitamin D metabolites in human serum
por: Müller, Miriam J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qkil2aa6rf20rqk3kq1tq2d2id